• Latest
Trump

Turn the corner

October 3, 2025
India’s office market sees 11 pc growth in April-June

Real estate fundraising hits 7-year high in FY25

October 23, 2025
ISRO to launch US BlueBird-6 satellite by year-end

ISRO to launch US BlueBird-6 satellite by year-end

October 23, 2025
‘Indian doctors in Stanford list of world’s top 2 pc scientists a proud moment’

‘Indian doctors in Stanford list of world’s top 2 pc scientists a proud moment’

October 23, 2025
S Jaishankar

Jaishankar to represent PM Modi at East Asia Summit

October 23, 2025
Bellingham's strike sees Madrid edge Juventus

Bellingham’s strike sees Madrid edge Juventus

October 23, 2025
growth

Bhai Dooj generates Rs 22,000 cr in business

October 23, 2025

India committed to rules-based multilateral trading system: Goyal

October 23, 2025
PM Modi to attend ASEAN-India Summit virtually

PM Modi to attend ASEAN-India Summit virtually

October 23, 2025
Banks performing exceptionally well: Sitharaman

Sitharaman highlights surge in Diwali sales to all-time high of Rs 6.05 lakh cr

October 22, 2025
Bumrah

Bumrah continues to retain top Test spot in ICC rankings

October 22, 2025
Artificial intelligence

MeitY proposes mandatory labels, metadata tagging to combat deepfakes

October 22, 2025
India, Japan underscore shared resolve to uphold maritime order in Indo-Pacific

India, Japan underscore shared resolve to uphold maritime order in Indo-Pacific

October 22, 2025
Blitzindiamedia
Contact
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Education
    • Health
    • Sports
    • Entertainment
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • US (New York)
    • UK (London)
    • Middle East (Dubai)
    • Tanzania (Africa)
  • Blitz India Business
No Result
View All Result
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Education
    • Health
    • Sports
    • Entertainment
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • US (New York)
    • UK (London)
    • Middle East (Dubai)
    • Tanzania (Africa)
  • Blitz India Business
No Result
View All Result
World's first weekly chronicle of development news
No Result
View All Result

Turn the corner

by Blitz India Media
October 3, 2025
in Opinion
Trump
Deepak Dwivedi

NEW DELHI: BY imposing a prohibitive 100 per cent tariff on imports of ‘branded’ and patented medicines, US President Donald Trump wants to force all suppliers of high-value proprietary medicines in the US to make them locally. He also wants home-grown elements of Big Pharma to shun offshoring of pharmaceutical manufacturing and research.

However, the stratospheric tariff is unlikely to help him meet the chief goal of gaining control over the global supply chains of medicines. Businesses rarely accept models forced on them; rather they find ways to bypass such hurdles, and grow autonomously. Global drug research and the business of manufacturing new drugs have already seen a fair amount of diversification in recent years, with China emerging as a key destination.

YOU MAY ALSO LIKE

Timely and critical

Paving way for greener future

Also, the conventional Big Pharma of the West is turning risk-averse. New blockbuster drugs aren’t hitting the market as frequently as the existing ones losing patent cover. Indian companies have a 40 per cent share in the US generics market by volume, while they account for just 13 per cent by value. This shows how valuable the high-quality Indian generic medicines are to the US consumers, when it comes to curbing healthcare costs. India has nearly 500 manufacturing units approved by the US Food and Drug Administration, second only to the number of such units in the US itself (530).

Given all this, the country’s generic drugs business is largely immune to the hefty US tariff. In fact, even a 30-80 per cent cut in prices of prescription drugs announced by Trump in May did not require Indian firms to cut their prices much. Nevertheless, the tariff may still have an impact on many of them, considering the varying nature of their business models. Apart from direct generic exports to the US, several of them also act as contract manufacturers for suppliers of branded /patented medicines.

India-made drugs reach the US market with labels belonging to firms based in the European Union (EU), Latin America, and elsewhere. Some of the larger Indian companies like Sun Pharma, Cipla, Dr Reddy’s, Lupin, and Biocon already have operational plants in the US, but they may still have to shift the entire production base for US supplies to that country to fully circumvent the 100 pc tariff.

That said, Trump’s policies may serve as a blessing in disguise for the domestic drug-makers, by shaking them out of complacency. The immediate strategy must include acquiring a greater share from China in the manufacturing of newly launched drugs, and expanding the branded drugs business in various export markets. A great deal of value usurped by the brand owners and monopolistic drug distributors in the global markets could accrue to Indian firms, with reasonable levels of additional investments.

Though fundamental drug research is still a tall order for India, at least a handful of companies would do well to explore this area. What awaits them is rich rewards from international patenting of their discoveries, in therapeutic areas where domestic and global market potentials converge. A revamped strategy is all the more important, especially because the public interest safeguards in India’s Patent Act, which have over the last two decades stood domestic industry in good stead, are being undermined under bilateral free trade pacts with major partners like the UK, European Free Trade Association, EU, and even the US.

Previous Post

Securing minerals of tomorrow

Next Post

A banyan tree

Related Posts

Timely and critical
Opinion

Timely and critical

October 17, 2025
Paving way for greener future
Opinion

Paving way for greener future

October 17, 2025
upi
Opinion

UPI: The face of India’s innovation

October 10, 2025
Securing minerals of tomorrow
Opinion

Securing minerals of tomorrow

October 3, 2025
modi
Opinion

A timely call

September 26, 2025
rail
Opinion

A rail renaissance

September 26, 2025

Recent News

India’s office market sees 11 pc growth in April-June

Real estate fundraising hits 7-year high in FY25

October 23, 2025
ISRO to launch US BlueBird-6 satellite by year-end

ISRO to launch US BlueBird-6 satellite by year-end

October 23, 2025
‘Indian doctors in Stanford list of world’s top 2 pc scientists a proud moment’

‘Indian doctors in Stanford list of world’s top 2 pc scientists a proud moment’

October 23, 2025
S Jaishankar

Jaishankar to represent PM Modi at East Asia Summit

October 23, 2025
Bellingham's strike sees Madrid edge Juventus

Bellingham’s strike sees Madrid edge Juventus

October 23, 2025
growth

Bhai Dooj generates Rs 22,000 cr in business

October 23, 2025

India committed to rules-based multilateral trading system: Goyal

October 23, 2025
PM Modi to attend ASEAN-India Summit virtually

PM Modi to attend ASEAN-India Summit virtually

October 23, 2025
Banks performing exceptionally well: Sitharaman

Sitharaman highlights surge in Diwali sales to all-time high of Rs 6.05 lakh cr

October 22, 2025
Bumrah

Bumrah continues to retain top Test spot in ICC rankings

October 22, 2025
Artificial intelligence

MeitY proposes mandatory labels, metadata tagging to combat deepfakes

October 22, 2025
India, Japan underscore shared resolve to uphold maritime order in Indo-Pacific

India, Japan underscore shared resolve to uphold maritime order in Indo-Pacific

October 22, 2025

Blitz Highlights

  • Special
  • Spotlight
  • Insight
  • Entertainment
  • Health
  • Sports

International Editions

  • US (New York)
  • UK (London)
  • Middle East (Dubai)
  • Tanzania (Africa)

Nation

  • East
  • West
  • South
  • North
  • Hindi Edition

E-paper

  • India
  • Hindi E-paper
  • Dubai E-Paper
  • USA E-Paper
  • UK-Epaper
  • Tanzania E-paper

Useful Links

  • About us
  • Contact
  • Team
  • Privacy Policy
  • Sitemap

©2024 Blitz India Media -Building A New Nation

    No Result
    View All Result
    • Blitz Highlights
      • Special
      • Spotlight
      • Insight
      • Education
      • Sports
      • Health
      • Entertainment
    • Opinion
    • Legal
    • Perspective
    • Nation
      • East
      • West
      • North
      • South
    • Business & Economy
    • World
    • Hindi Edition
    • International Editions
      • US (New York)
      • UK (London)
      • Middle East (Dubai)
      • Tanzania (Africa)
    • Download
    • Blitz India Business

    © 2025 Blitz India Media -BlitzIndia Building A New Nation